Melanoma in Mice Stress / Damage and Delays Onset of Ultraviolet-Induced-Acetylcysteine Protects Melanocytes against Oxidative N Updated
M. Cotter,JoshuaThomas,P. Cassidy,Kyle Robinette,NoahJenkins,S. Florell,S. Leachman,W. Samlowski,D. Grossman
Abstract:Purpose: UV radiation is the major environmental risk factor for melanoma and a potent inducer of oxidative stress, which is implicated in the pathogenesis of several malignancies.We evaluated whether the thiol antioxidant N-acetylcysteine (NAC) could protect melanocytes from UVinduced oxidative stress/damage in vitro and from UV-inducedmelanoma in vivo. Experimental Design: In vitro experiments used the mouse melanocyte line melan-a. For in vivo experiments, mice transgenic for hepatocyte growth factor and survivin, shownpreviously to developmelanoma following a single neonatal dose of UV irradiation, were givenNAC (7mg/mL; mother’s drinkingwater) transplacentally and throughnursing until 2 weeks after birth. Results: NAC (1-10 mmol/L) protected melan-a cells from several UV-induced oxidative sequelae, including production of intracellular peroxide, formation of the signature oxidative DNA lesion 8-oxoguanine, and depletion of free reduced thiols (primarily glutathione).Delivery of NAC reduced thiol depletion andblocked formationof 8-oxoguanine inmouse skin following neonatal UV treatment. Mean onset of UV-induced melanocytic tumors was significantly delayed in NAC-treated compared with control mice (21versus14 weeks; P = 0.0003). Conclusions:Our data highlight the potential importance of oxidative stress in the pathogenesis of melanoma and suggest that NACmay be useful as a chemopreventive agent. Melanoma is an increasingly prevalent cutaneous malignancy. In advanced stages, melanoma is an aggressive cancer that is generally unresponsive to conventional therapies and associated with poor prognosis (1). Individuals with personal or family history of melanoma or those with increased numbers of nevi or atypical nevi are at increased risk for developing melanoma (2). The best characterized environmental risk factor for melanoma is UV radiation from the sun (3). In the past decade, there has been an increased emphasis on melanoma prevention focusing on patient education and sun protection (4). Despite these efforts, melanoma rates have continued to increase (1). A chemoprevention strategy would thus be useful in high-risk patients if a safe, well-tolerated, and easily administered agent could be developed targeting a critical pathway in melanomagenesis. Reactive oxygen species (ROS), including hydrogen peroxide, superoxide anion, singlet oxygen, and hydroxyl radical, are induced in the skin by UV irradiation (5). These ROS are short-lived molecules that are capable of causing oxidative damage in DNA, as well as cellular protein and lipids, leading to permanent genetic changes and activating signal transduction pathways that promote skin carcinogenesis (6). In addition to peroxidation of cellular substrates, UV-induced ROS can damage cells by decreasing vital intracellular reductants, such as glutathione (GSH). Melanocytes are particularly sensitive to oxidative stress (7), which is chronically generated during melanogenesis (8) due to the pro-oxidant effect of melanin (9). Melanoma tissues exhibit increased products of lipid peroxidation and levels of antioxidant enzymes compared with benign nevi (10), and oxidative dysregulation is correlated with melanoma progression in a mouse model (11). These observations support the notion that UV-induced oxidative stress/damage contributes to melanoma pathogenesis (12) and could be targeted using antioxidant preventive therapy. The thiol N-acetylcysteine (NAC), a cell-permeable GSH prodrug/antioxidant (13), is Food and Drug Administration approved for the treatment of acetaminophen toxicity (14) and has been used at high oral doses in humans for chronic treatment of idiopathic pulmonary fibrosis (15). In a mouse model of chronic UV-induced squamous cell carcinoma, orally administered NAC reduced tumor formation (16). Additionally, topical NAC reduced UV-mediated GSH depletion and peroxide induction in normal human skin (17). NAC also seems to have some anticancer effects independent of its role as an antioxidant. It has specifically been shown to decrease VEGF Cancer Susceptibility and Prevention Authors’ Affiliations: Departments of Dermatology, Oncological Sciences, Medicinal Chemistry, Medicine, and Melanoma Program, Huntsman Cancer Institute, University of Utah Health Science Center, Salt Lake City, Utah Received 5/14/07; revised 6/21/07; accepted 7/18/07. Grant support: NIH grants AR050102 and CA125761 (D. Grossman) and RR17525 (S.R. Florell) and the Huntsman Cancer Foundation. T32 training grant CA093247 (M.A. Cotter). The costs of publication of this article were defrayed in part by the payment of page charges.This article must therefore be hereby marked advertisement in accordance with18 U.S.C. Section1734 solely to indicate this fact. Requests for reprints: Doug Grossman, Huntsman Cancer Institute, Suite 5243, 2000 Circle of Hope, Salt Lake City, UT 84112. Phone: 801-581-4682; Fax: 801585-0900; E-mail: doug.grossman@hci.utah.edu. F2007 American Association for Cancer Research. doi:10.1158/1078-0432.CCR-07-1187 www.aacrjournals.org Clin Cancer Res 2007;13(19) October1, 2007 5952 Cancer Research. on February 25, 2014. © 2007 American Association for clincancerres.aacrjournals.org Downloaded from production in melanoma cells in vitro (18) and decrease matrix metalloproteinase activity in invasive tumor cells (19). Thus, in addition to its demonstrated safety record, NAC has the capacity to modulate both UV-induced oxidative stress and carcinogenesis in the skin. In this study, we conducted a trial of orally administered NAC in a highly penetrant mouse model of melanoma (20), in which animals develop tumors following a single UV exposure in the neonatal period. Additionally, we characterized the generation of oxidative stress/damage following UV irradiation of a mouse melanocyte cell line and mouse skin. Administration of NAC to cultured cells or animals before UV irradiation resulted in a reduction in oxidative stress/damage in both melanocytes and whole skin and a significant delay in tumor formation. We conclude that NAC seems to be a promising candidate agent for melanoma chemoprevention, which may be applicable to human trials. Materials andMethods